Enhanced sensitivity of neutralizing antibody detection for different AAV serotypes using HeLa cells with overexpressed AAVR
A cell-based transduction inhibition assay (TI) is widely used in clinical trials to detect neutralizing antibody (NAb) titers against recombinant adeno-associated virus (rAAV), one of the most important criteria to exclude patients in gene therapy. Different cell lines are used in cell-based TI bec...
Main Authors: | Zhaoyue Zheng, Jingya Ye, Mi Leng, Chunmei Gan, Na Tang, Wei Li, C. Alexander Valencia, Biao Dong, Hoi Yee Chow |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-04-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1188290/full |
Similar Items
-
Structural basis of receptor usage by the engineered capsid AAV-PHP.eB
by: Seongmin Jang, et al.
Published: (2022-09-01) -
Adeno-associated virus receptor complexes and implications for adeno-associated virus immune neutralization
by: Edward E. Large, et al.
Published: (2023-02-01) -
Engineering a highly durable adeno-associated virus receptor for analytical applications
by: Kouhei Yoshida, et al.
Published: (2023-12-01) -
High concordance of ELISA and neutralization assays allows for the detection of antibodies to individual AAV serotypes
by: Matthew R. Gardner, et al.
Published: (2022-03-01) -
The Structure of an AAV5-AAVR Complex at 2.5 Å Resolution: Implications for Cellular Entry and Immune Neutralization of AAV Gene Therapy Vectors
by: Mark A. Silveria, et al.
Published: (2020-11-01)